N-(5-acetyl-1,3-thiazol-2-yl)-2,2-dimethylpropanamide, 95.0%, 10g

Ethyl 3-(3,4-dichlorophenyl)-[1,2,4]oxadiazole-5-carboxylate, 95.0%, 5g

Piperazine-2-carboxylic acid, 98.0%, 100g

Óxido de indio en polvo 99,9% 100 g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)hept-6-ynoic acid, 97%, 5g

Tapón de llave de paso, 18,8, 6,0 mm, 2 Pieza(s)

Fmoc-L-homoserine, 98%, 25g

((1r,3r)-3-Methoxycyclobutyl)methanol, 98%, 100mg

tert-Butyl 2-bromo-4,5-dihydrothieno[2,3-c]pyridine-6(7H)-carboxylate, 95.0%, 1g

(S)-4-PHENYL-2-(QUINOLIN-2-YL)-4,5-DIHYDROOXAZOLE, 95%, 100mg

N-(3-(3-Bromopyrazolo[1,5-a]pyrimidin-7-yl)phenyl)-3-(trifluoromethyl)benzamide, 95.0%, 1g

Caldo YPD, 500 g

Pentanoic acid, 2-acetyl-2-propyl-, methyl ester, 98%, 250mg